Statin therapy

Statin therapy reduces vascular events in 'low-risk' people

Professor Anthony Keech, Dr Jordan Fulcher and Professor John Simes have questioned whether more people should be eligible for lipid-lowering therapy. Their discourse, published in an editorial in the Medical Journal of Australia, draws on a recent meta-analysis of evidence by the Cholesterol Treatment Trialists' Collaboration, of which Professors Keech and Simes are members.

The study, published in The Lancet, analysed data from 170,000 patients with or without cardiovascular disease, and showed that treatment with statins resulted in significant reductions in vascular events, such as strokes and heart attacks, in patients with no history of vascular disease.